Efficacy of sulphadoxine-pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old

Tropical Medicine and International Health

Volumn 5, Issue 5, 2000, Pages 355-358

  Nwanyanwu, Okey C ^a,c   Ziba, Charles ^a   Macheso, Allan ^a   Kazembe, Peter ^b  

^a MINISTRY OF HEALTH   (Malawi)

^b KAMUZU CENTRAL HOSPITAL   (Malawi)

^c NONE   (Mozambique)

Author keywords

Children; Clinical failure; Falciparum malaria; Malawi; Resistance; Sulphadoxine pyrimethamine

Indexed keywords

CHLOROQUINE; PYRIMETHAMINE; SULFADOXINE;

AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DISEASE CONTROL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; OUTPATIENT; PARASITEMIA; PLASMODIUM FALCIPARUM; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

ACUTE DISEASE; ANTIMALARIALS; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PYRIMETHAMINE; SULFADOXINE;

EID: 0034088179     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2000.00554.x     Document Type: Article

References (5)

1. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R & Campbell CC (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases 167, 932-937.
2. Dean AG, Dean JA, Coulombier D et al. (1994) Epi Info, Version 6: a word processing, database and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta.
3. Heymann DL, Khoromana CO, Wirima JJ & Campbell CC (1987) Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 722-724.
4. Ministry of Health Malawi (1992) Guidelines for the Management of Malaria. MoH, Lilongwe.
5. World Health Organization (1996) Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas of intense transmission. WHO, Geneva.